GASTROINTESTINAL NEUROENDOCRINE CARCINOMA

Clinical trials for GASTROINTESTINAL NEUROENDOCRINE CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new GASTROINTESTINAL NEUROENDOCRINE CARCINOMA trials appear

Sign up with your email to follow new studies for GASTROINTESTINAL NEUROENDOCRINE CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New oral drug trial offers hope for Tough-to-Treat cancers

Disease control Recruiting now

This study is testing an experimental oral medication called ESK981 for people with advanced pancreatic cancer and certain neuroendocrine cancers that have stopped responding to standard treatments. The trial will enroll 66 patients across three groups to see if taking ESK981 on …

Matched conditions: GASTROINTESTINAL NEUROENDOCRINE CARCINOMA

Phase: PHASE2 • Sponsor: University of Michigan Rogel Cancer Center • Aim: Disease control

Last updated Mar 30, 2026 14:35 UTC

GASTROINTESTINAL NEUROENDOCRINE CARCINOMA

Get alerted when new GASTROINTESTINAL NEUROENDOCRINE CARCINOMA trials appear

New oral drug trial offers hope for Tough-to-Treat cancers